Source: European Medicines Agency (EU) Revision Year: 2026 Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
VFEND 50 mg film-coated tablets.
VFEND 200 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
VFEND 50 mg film-coated tablets: White to off-white, round tablet, debossed "Pfizer" on one side and "VOR50" on the reverse (tablets). VFEND 200 mg film-coated tablets: White to off-white, capsule-shaped tablet, debossed "Pfizer" on one side and "VOR200" on the reverse (tablets). |
Each tablet contains 50 or 200 mg voriconazole.
Excipient with known effect:
VFEND 50 mg film-coated tablets: Each tablet contains 63.42 mg lactose monohydrate.
VFEND 200 mg film-coated tablets: Each tablet contains 253.675 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Voriconazole is a triazole antifungal agent. The primary mode of action of voriconazole is the inhibition of fungal cytochrome P450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Film-coating: Hypromellose |
PVC/Aluminium blister in cartons of 2, 10, 14, 20, 28, 30, 50, 56 or 100 film-coated tablets.
PVC/Aluminium/PVC/PVDC blister in cartons of 2, 10, 14, 20, 28, 30, 50, 56 or 100 film-coated tablets.
Not all pack sizes may be marketed.
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
VFEND 50 mg film-coated tablets:
EU/1/02/212/001-009
EU/1/02/212/028-036
VFEND 200 mg film-coated tablets:
EU/1/02/212/013-021
EU/1/02/212/037-045
Date of first authorisation: 19 March 2002
Date of latest renewal: 21 February 2012
| Drug | Countries | |
|---|---|---|
| VFEND | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.